on 28 Jun 2022
Last Applicant/ Owned by
5959 Horton Street, Suite 300
Emeryville
CA
94608
Serial Number
88030324 filed on 09th Jul 2018
Registration Number
6775121 registered on 28th Jun 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Conducting evaluations in the field of pharmaceuticals; pharmaceutical product development and evaluation services; pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; scientific research services, namely, collection of specifi Read More
Conducting evaluations in the field of pharmaceuticals; pharmaceutical product development and evaluation services; pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients
17th Sep 2016
17th Sep 2016
No 88030324
No Service Mark
No GRITST.003TM
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
28th Jun 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
28th Jun 2022 | REGISTERED-PRINCIPAL REGISTER |
21st May 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
20th May 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
20th May 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
20th May 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
20th May 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
01st Apr 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
01st Apr 2022 | NON-FINAL ACTION E-MAILED |
01st Apr 2022 | SU - NON-FINAL ACTION - WRITTEN |